NCT01033019 To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC) Status TERMINATED Phase PHASE2
NCT01032915 Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis Status TERMINATED Phase PHASE3
NCT01031628 Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients Status TERMINATED Phase PHASE3
NCT01031381 Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer Status COMPLETED Phase PHASE2
NCT01031212 ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors Status WITHDRAWN Phase PHASE1
NCT01030952 Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion Status COMPLETED Phase PHASE4
NCT01030055 Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01029652 Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study Status COMPLETED Phase PHASE3
NCT01028222 A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation Status COMPLETED Phase PHASE2
NCT01025817 Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients Status COMPLETED Phase PHASE3
NCT01024946 Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity Status COMPLETED Phase PHASE2
NCT01023542 CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation Status UNKNOWN Phase PHASE2/PHASE3
NCT01023308 Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01022996 Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment. Status COMPLETED Phase PHASE2
NCT01022970 Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis Status COMPLETED Phase PHASE2
NCT01019980 Efficacy of Diclofenac Potassium Versus Acetaminophen in Febrile Children With Acute Upper Respiratory Tract Infections Status TERMINATED Phase PHASE4
NCT01019473 Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea Status TERMINATED Phase PHASE2
NCT01018693 A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance Status COMPLETED Phase PHASE2
NCT01018225 Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness Status WITHDRAWN Phase PHASE4